Cristal Therapeutics

Netherlands
Maastricht, Limburg, The Netherlands, 6229 EV

Company profile

Cristal Therapeutics company profile

Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies. It aims to find valuable solutions for medical needs by creating superior drug products. Both new and existing drugs can be combined with Cristal Therapeutics Polymeric Technologies, shortly abbreviated as CriPec. CriPec-based products are versatile as a crystal and allow to improve the treatment of various diseases.

Business identity

Contact email
[email protected]
Phone number
+31433885868
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2011-01-01, Year

Headquarters

Postal code
6229 EV
Country code
NL
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
4
Total equity funding
$21.1M
Last funding
Grant / $3M / 2017-11-28
Last equity funding
Series Unknown / $13.6M
Investors
11
Lead investors
3
Founders
2
Articles
7

Founders and investors

Founders

Cristianne RijckenJoost Holthuis

Lead investors

Aglaia BioMedical VenturesDroia VenturesHorizon 2020

Investors

BioGeneration VenturesBOMDroia VenturesEISMEAThuja Capital